Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 39 of the 51 sources its claims cite were checked for support.

Progress on the correlation between sepsis and gut microbiota: a narrative review

Open access
Yuan, Yaning, Li, Jiawei, Yang, Cheng · 2026 · Frontiers in microbiology

Abstract

Background: Sepsis is a life-threatening organ dysfunction with high mortality. Gut microbiota plays a key role in sepsis pathogenesis, but evidence is often mixed. Methods: This narrative review is based on a structured literature search (PubMed, Web of Science, Cochrane; from database inception to March 15, 2025). Findings are stratified into clinical (human), preclinical (animal), and unsafe/unproven categories. Results: Sepsis and gut microbiota form a bidirectional vicious cycle. Sepsis induces dysbiosis via ischemia, inflammation, and broad-spectrum antibiotics - the strongest iatrogenic driver. Dysbiosis in turn amplifies organ dysfunction through gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen axes. Clinically, adequate source control and antibiotic de-escalation are mandatory before any microbiota-directed therapy. Microbiota-targeted interventions show promise but carry significant risks: live probiotics are contraindicated in septic shock, severe pancreatitis, and immunocompromised patients (PROPATRIA trial). Conclusion: This evidence-stratified review provides a clinical roadmap: prioritize source control and antibiotic stewardship; avoid live probiotics in high-risk sepsis. Future research requires large RCTs and personalized strategies.

Overview

CoChat Summary

## TL;DR

This narrative review argues that sepsis and gut microbiota reinforce each other in a vicious cycle: sepsis drives dysbiosis, and dysbiosis worsens organ dysfunction through barrier failure, immune-metabolic disruption, and gut-organ axes. The review concludes that source control and antibiotic stewardship come before any microbiota-directed therapy, and that live probiotics should be avoided in high-risk septic patients.

## Key findings

  • Sepsis-induced dysbiosis is driven by ischemia/reperfusion injury, systemic inflammatory mediators, and iatrogenic factors; the review identifies broad-spectrum antibiotics as the strongest iatrogenic driver of dysbiosis.
  • Dysbiosis can amplify organ failure through multiple gut-organ axes, including gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen pathways.
  • Clinically, source control and antibiotic de-escalation are mandatory before microbiota-directed therapy; the paper also notes that inadequate source control makes microecological interventions unlikely to succeed and potentially harmful.
  • Live probiotics are flagged as unsafe in high-risk settings: in the PROPATRIA trial, severe acute pancreatitis patients had increased gut necrosis (9/152 vs. 0/144) and mortality (24/152 vs. 9/144); the review says they should not be routinely used in septic shock, severe acute pancreatitis, or immunocompromised patients.

## Methods

  • Narrative review based on a structured literature search of PubMed, Web of Science, and Cochrane Library from database inception to March 15, 2025.
  • Included clinical studies, animal experiments, and mechanistic studies; case reports and non-microbiome studies were excluded.
  • Findings were stratified into clinical (human), preclinical (animal), and unsafe/unproven categories, with evidence graded throughout as clinical, preclinical, clinical/preclinical, or clinical warning.

## Limitations

  • The paper states that relevant studies remain scarce, and that the specific mechanisms and clinical implications are still unclear.
  • It explicitly notes that evidence for many interventions is limited: synbiotics have only small studies, FMT for sepsis has only preclinical/animal studies, and human trials are lacking for postbiotics.
  • Evident from the text: as a narrative review, it synthesizes heterogeneous studies rather than presenting new patient-level data or a quantitative meta-analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fmicb.2026.1862891

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Bidirectional interplay between sepsis and gut microbiota. The schematic illustrates how sepsis triggers gut dysbiosis (left/upper part) and how dysbiosis subsequently amplifies sepsis severity (right/lower part), forming a self-reinforcing vicious cycle. Key mechanisms include bacterial translocation, immune dysregulation, and metabolic disturbances. SCFAs, short-chain fatty acids; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4.
Figure 1 Bidirectional interplay between sepsis and gut microbiota. The schematic illustrates how sepsis triggers gut dysbiosis (left/upper part) and how dysbiosis subsequently amplifies sepsis severity (right/lower part), forming a self-reinforcing vicious cycle. Key mechanisms include bacterial translocation, immune dysregulation, and metabolic disturbances. SCFAs, short-chain fatty acids; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4.CC BY · PubMed Central
Figure 2 Schematic diagram of the gut-organ axes in sepsis. Sepsis induces gut dysbiosis, which subsequently drives organ dysfunction via multiple axes: gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen axes (detailed mechanisms shown in the figure). A red dashed arrow indicates the self-reinforcing vicious cycle. SCFAs, short-chain fatty acids; LPS, lipopolysaccharide; TMAO, trimethylamine N-oxide; SAE, sepsis-associated encephalopathy; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury.
Figure 2 Schematic diagram of the gut-organ axes in sepsis. Sepsis induces gut dysbiosis, which subsequently drives organ dysfunction via multiple axes: gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen axes (detailed mechanisms shown in the figure). A red dashed arrow indicates the self-reinforcing vicious cycle. SCFAs, short-chain fatty acids; LPS, lipopolysaccharide; TMAO, trimethylamine N-oxide; SAE, sepsis-associated encephalopathy; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury.CC BY · PubMed Central

Verification

Claims the paper makes

26 Valid · 8 Not valid · 7 Not checked · 15 Own results and interpretations

24 more claims · 15 with their cited sources checked

Create a free account to see all 56 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 10

Create a free account to see these claims.

Citations

Cites

Show all 58 references

Metadata

Authors
Yuan, Y., Li, J., & Yang, C.
Affiliations
  • Sichuan University (CN)
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education
Corresponding author
Yang, Cheng
Venue
Frontiers in microbiology
Published
2026-06-03
Volume
17
Pages
1862891-1862891
ISSN
1664-302X (ISSN-L)
OpenAlex
W7163393789
Cited by
1
References
58
Citations by year
2026: 1
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
Keywords
sepsis, gut microbiota, dysbiosis, gut-brain axis, gut-lung axis, gut-liver axis, gut-kidney axis, gut-heart axis, septic shock, antibiotic de-escalation, antibiotic stewardship, source control, probiotics, immunocompromised patients, severe pancreatitis, organ dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Progress on the correlation between sepsis and gut microbiota: a narrative review. https://app.cochat.ai/papers/10.3389/fmicb.2026.1862891
The paper
Yuan, Y., Li, J., & Yang, C. (2026). Progress on the correlation between sepsis and gut microbiota: a narrative review. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2026.1862891

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.